Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,210 total articles
SunScout Holding Limited, a New Zealand-based clean technology company specializing in autonomous solar-powered robotic mowers, has priced its initial public offering of 3.1 million shares at $5.00 each, raising $15.5 million before expenses. The shares will be dual-listed on NYSE American and NYSE Texas under the ticker SNSC. Proceeds will fund a …
Fusion Fuel Green PLC announced that its subsidiary BrightHy Solutions has completed key execution milestones on two green hydrogen projects in Southern Europe, including the completion of the FEED package for a 15 MW green hydrogen production facility and successful factory acceptance tests for a hydrogen refueling station. These advances position…
Tri Pointe Homes, one of the largest homebuilders in the U.S., has been named to the 2026 PEOPLE Companies That Care list for the fourth consecutive year, underscoring its dedication to fostering a supportive workplace culture, employee empowerment, sustainable business practices, and community engagement. This recognition is based on extensive emp…
Haoxi Health Technology Limited announced a reverse share split of its Class A and Class B ordinary shares at a ratio of 1-for-20 effective August 14, 2026. The split will reduce the number of outstanding shares and increase the share price accordingly on Nasdaq, where the stock trades under ticker HAO. No fractional shares will be issued; fraction…
Madrigal Pharmaceuticals, a biopharmaceutical company specializing in treatments for metabolic dysfunction-associated steatohepatitis (MASH), announced the appointment of Dr. John C. Reed to its Board of Directors. Dr. Reed brings extensive leadership experience in drug discovery and development from his roles at Johnson & Johnson, Sanofi, and Roch…
Bone Biologics Corporation announces the extension of the validated shelf life of its rhNELL-1 protein to 32 months, improving flexibility in manufacturing, storage, and distribution as it advances its pilot clinical study for spinal fusion applications. This milestone supports operational efficiency and supply chain flexibility for the company's l…
Twin Disc, Inc. (NASDAQ: TWIN) announced the release date for its fiscal 2026 fourth-quarter earnings, set for August 20, 2026, along with a webcast and conference call to discuss the results. The company manufactures marine and heavy-duty off-highway power transmission equipment, serving multiple markets including marine, energy, military, and ind…
Teck Resources Limited obtained majority consents from holders of its outstanding notes to approve proposed amendments aligning debt covenants with those of Anglo American plc in anticipation of an expected merger. The consent solicitations have expired, amendments have been executed, and consent fees will be paid. The merger between Teck and Anglo…
Nexera Technologies' majority-owned subsidiary, Fort Technology Inc., has signed agreements to acquire a 50.1% stake in Logia USA, a company focused on advanced fuel integrity solutions for data centers and mission-critical facilities in the U.S. The acquisition involves issuing shares valued at $125,000 and providing a $2 million credit facility t…
3 E Network Technology Group Limited announced the completion of the initial system-level architecture specification for its next-generation customized AI storage controller and preliminary validation of its core data flow algorithms through software simulation. This progress marks a key step in the development of hardware designed to overcome Inpu…
Adagene Inc. announced its financial results for the six months ended June 30, 2026, highlighting significant clinical advancements in its lead candidate muzastotug (ADG126), a masked anti-CTLA-4 antibody. The company reported encouraging efficacy and safety data in microsatellite stable colorectal cancer (MSS CRC) and hepatocellular carcinoma (HCC…
Xilio Therapeutics announced FDA clearance of its IND application for XTX501, a bispecific PD-1/masked IL-2 therapy targeting solid tumors. The company is advancing additional masked T cell engager programs with anticipated IND submissions in 2027. Q2 financials showed increased collaboration revenue and reduced net loss, with a strong cash runway …
Nexxen International Ltd. reported record second quarter 2026 financial results, with Contribution ex-TAC of $97.8 million and programmatic revenue of $95.2 million, reflecting double-digit year-over-year growth. The company achieved an all-time record for quarterly Connected TV (CTV) revenue, up 33% year-over-year. Nexxen advanced its AI technolog…
Nexxen announced key executive appointments including Chance Johnson as President, Kara Puccinelli as Chief Commercial Officer, and Kenneth Suh as Chief Business Officer to strengthen leadership as the company scales its AI-powered unified advertising platform. These appointments aim to enhance strategic client relationships, expand enterprise grow…
Arbutus Biopharma reported a solid financial position at the end of Q2 2026, including receipt of a $178 million settlement payment from Moderna. The company filed international patent enforcement lawsuits against Pfizer and BioNTech related to its lipid nanoparticle technology. It also obtained FDA Fast Track designation for imdusiran, its hepatit…
Altimmune, Inc. announced key advancements in its late-stage clinical program for pemvidutide, targeting metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company initiated a global Phase 3 PERFORMA trial in MASH, reported positive Phase 2 topline data in AUD, and co…
Rekor Systems announced that their GoSecure platform now includes patent-pending audio verification capabilities, applying cryptographic authentication to audio recordings. This extends their technology beyond video to meet growing demands from law enforcement, courts, financial institutions, and government agencies for verifiable and tamper-proof …
PolyPid Ltd. reports FDA acceptance with Priority Review for its NDA submission of D-PLEX100 aimed at preventing surgical site infections in abdominal colorectal surgeries. The FDA PDUFA goal date is set for November 28, 2026, ahead of prior guidance, with a potential commercial launch in early 2027 under an exclusive U.S. and Canada partnership wi…
BrainsWay Ltd. reported a strong second quarter 2026 with revenue increasing 35% year-over-year to $17.1 million, a more than doubling of adjusted EBITDA to $3.5 million, and record shipments of Deep TMS systems up 42%. The company raised its full-year 2026 revenue guidance to $68-$70 million and adjusted EBITDA to $13-$14 million, citing expanding…
Ming Shing Group Holdings Limited (NASDAQ: PMA), a Hong Kong-based company focused on wet trades works and graphene technology, announced entering into a stock purchase agreement to acquire Meals Through Seasons Limited, a company controlling MTHK which operates in organic agricultural supply chain, cold chain logistics, and product processing. The…
Unicycive Therapeutics announced its Q2 2026 financial results and provided a business update highlighting progress toward FDA approval of its lead drug candidate, oxylanthanum carbonate (OLC), for treating hyperphosphatemia in dialysis patients. The FDA has assigned a facility inspection to the third-party manufacturer, a prerequisite for NDA resu…
Electra Battery Materials Corporation announced the appointment of Peter Rawlins as its new CFO, effective August 26, 2026, bringing extensive mining finance and capital markets experience. The company reported Q2 2026 financial results showing progress in the construction of North America's first cobalt sulfate refinery in Ontario, with constructi…
Polar Power, Inc. announced $7.9 million in revenue from the Pacific Islands since 2024, driven by 333 shipments of DC power and solar-hybrid systems to countries including Papua New Guinea and Fiji. Repeat orders from telecommunications customers indicate growing adoption and reliability of its technology. The company is now expanding into adjacen…
Milestone Pharmaceuticals announced Q2 2026 financial results and corporate updates, reporting increased patient and prescriber adoption of its FDA-approved cardiovascular drug CARDAMYST for PSVT, expanded insurance coverage to over 50% of commercially insured lives in the U.S., and initiation of a Phase 3 registrational trial for atrial fibrillati…
Kamada Ltd., a global biopharmaceutical company specializing in specialty plasma-derived therapies, announced record-high revenues and adjusted EBITDA for the first half and second quarter of 2026, driven by strong sales growth of its proprietary products like KEDRAB in the U.S., VARIZIG, and HEPAGAM. The company affirmed its 2026 annual financial …
